-
-
-
A 52-year-old woman had systemic symptoms including nausea and vomiting. Seven months prior to admission she had a subarachnoid hemorrhage and needed multiple ventriculo-pleural shunts.
-
Raltegravir (RAL) received FDA approval in 2007 and is now used in treatment of both treatment-experienced and treatment-naïve patients.
-
A previously healthy 51-year-old man with no history of travel outside of Montana presented to a local emergency department in May 2009 with fever, frontal headache, dizziness, numbness, and tingling.
-
A randomized, double-blind, placebo-controlled trial of immediate vs. deferred ART in 253 patients with HIV-associated TB meningitis was conducted to determine whether immediate ART reduced the risk of death.
-
The numbers of households with pets are increasing in many countries across the world. In addition, data obtained from media sources note a trend in the percentage of these pets sleeping in, or on, the owner's bed.
-
Thirty years into an epidemic that began with cryptic reports of a new disease among gay American men, there is this discouraging finding: AIDs Studies and reports worldwide point to a resurgent HIV epidemic among men who have sex with men (MSM).
-
Uldrick et al performed a pilot study in which 14 HIV-infected patients with symptomatic MCD received high-dose AZT (600 mg PO Q6 hours) and VGC (900 mg PO Q12 hours). Eighty-six percent of patients attained major clinical responses (defined as resolution of symptoms and at least partial resolution of lymphandenopathy).
-
The search for an HIV vaccine will continue, but in the meantime, there is little doubt that an aggressive HIV screening and early treatment strategy could make a big impact on reducing HIV transmission.
